Skip to main content

Table 3 Baseline clinical characteristics for PLH receiving ART care in Dar es Salaam, Tanzania

From: CLINICAL outcomes and loss to follow-up among people living with HIV participating in the NAMWEZA intervention in Dar es Salaam, Tanzania: a prospective cohort study

Characteristics

Comparison

Intervention

p value1

Mean CD4 (SD)

270 (173.4)

308 (184.1)

0.76

Immune suppression

 Severe immunosuppression (CD4 < 200)

116 (28.5)

96 (23.1)

0.09

 Moderate immune suppression (CD4 = 200 to <350)

119 (29.2)

138 (33.2)

 

 Not immune suppressed (CD4 ≥ 350)

173 (42.4)

182 (43.8)

 

Mean hemoglobin (SD)

10 (2.1)

9 (1.9)

0.09

Low hemoglobin(anemia) mean (SD)

11 (2.6)

5 (1.2)

 

 Severe anemia (<8.5)

60 (14.7)

52 (12.5)

0.03

 Moderate anemia (8.6 to <10)

179 (43.9)

278 (88.8)

 

 Mild anemia (10 to <12)

122 (29.9)

81 (19.5)

 

No anemia (>12)

44 (9.0)

91 (22.0)

 

Mean weight (kg) (SD)

60 (11.9)

61 (12.7)

0.33

Weight groups (kg)

  

0.21

 <45

72 (18.6)

21 (5.1)

 

 45–60

88 (21.6)

50 (12.0)

 

 >60

227 (55.6

341 (82.0)

 

Mean duration on ART at baseline, mean (SD)

18 (17.0)

20 (16.0)

0.23

  1. N-intervention group = 412 and 367 control group: A total of 21 participants in the comparison group and 4 in the intervention had missing data and were omitted
  2. 1p-value was obtained from Chi Square test